The purpose of this study was to determine the effect of vasoactive substances released by aggregating platelets on adrenergic neurotransmission in canine coronary arteries. Isometric tension was recorded in isolated ring segments of coronary artery denuded of endothelium and the release of VIHlnorepinephrine was measured from strips of coronary artery preincubated with the radiolabeled transmitter. Transmural electrical field stimulation and exogenously added norepinephrine caused beta adrenergic relaxations of coronary rings contracted by prostaglandin F2.
Introduction
Platelets aggregate at sites ofdamage to the vascular endothelium (1) . The release of vasoactive substances by the platelets may influence the smooth muscle of the arterial wall. Coronary arterial endothelial cells may respond to platelet-released 5-hydroxytryptamine and adenine nucleotides and cause relaxation of isolated coronary smooth muscle (2) (3) (4) (5) . If the endothelium is damaged, 5-hydroxytryptamine (2, 3, 6) and thromboxane A2 (7) released by aggregating platelets have been shown to contract coronary arteries. Beta adrenergic neurotransmission which has been demonstrated in isolated epicardial canine coronary arteries (8) would be expected to oppose the contractile influence exerted Received for publication 3 April 1985 and in revised form 3 October 1985. by platelets. A previous study has demonstrated, however, that after exposure ofcanine coronary arteries to aggregating platelets, neurogenic serotonergic contractions resulted from accumulation of 5-hydroxytryptamine in the adrenergic nerve endings (9) . The present study was performed to further determine the effects on adrenergic neurotransmission in canine coronary artery during exposure to aggregating platelets.
Methods
The heart was removed from mongrel dogs after anesthesia with sodium pentobarbital (30 mg/kg, i.v.) and exsanguination; the epicardial coronary arteries were immediately dissected free.
Organ bath experiments. Rings of left circumflex artery 6 mm in length were studied in organ chambers (25 ml) filled with physiological salt solution ofthe following millimolar composition: NaCl, I18.3; KC1, 4.7; MgSO4, 0.6; KH2PO4, 1.2; CaCI2, 2.5; NaHCO3, 25.0; calcium EDTA, 0.026; and glucose, 1 1.1. The solution was maintained at 37°C and gassed with 95% 02; 5% C02. In order to eliminate endotheliumdependent relaxation caused by aggregating platelets (2), the endothelium was removed from the rings by light mechanical abrasion of the intimal surface. Functional absence of endothelium was confirmed by failure of the ring contracted with prostaglandin F2 to relax in response to acetylcholine (10-6 M). The rings were connected to a strain gauge and resting tension was increased over 90 min to that which is optimal for contraction (8) . Transmural electrical stimulation of adrenergic nerves was accomplished with parallel platinum electrodes, a stimulator, and a direct current amplifier. Optimal nerve stimulation parameters (10 V, 0.1-0.3 ms pulse duration) were determined in each experiment such that responses to electrical stimulation were abolished by tetrodotoxin (10-M; reference 8). Rings were contracted with prostaglandin F2. (2 X 10-6 M) in order to study relaxation responses. Responses to increasing frequencies (0.5-16 Hz) were allowed to reach maximum before the frequencies were increased. All experiments were performed in the presence of indomethacin (3 X 10-' M; reference 8) and cocaine (3 X 10-' M).
Protocol. Two responses to electrical stimulation (SI and S2)1 were obtained in each ring contracted by prostaglandin F2,,. After SI and before S2, the ring was rinsed for 1 h and exposed for 20 min to either aggregating platelets, adenosine diphosphate (3 X 10' M), or 5-hydroxytryptamine (3 X 10-6 M) before addition of prostaglandin Fu,. Indomethacin was omitted before adding platelets, and re-added when the contraction caused by platelets had stabilized. After the later response to electrical stimulation, the tension was allowed to stabilize and norepinephrine or sodium nitroprusside was added to the organ chamber in cumulative half-log unit increments. The (2) . Platelet-rich plasma was obtained by centrifugation (180 g, 20 min). A platelet pellet was obtained (1600 g, 10 min), resuspended, and washed once in calcium-free saline containing 0.4% citrate at pH 6.5. The number of platelets in these suspensions was counted with a Coulter counter (Coulter Electronics Inc., Hialeah, FL) and suspensions were added to the physiological salt solution resulting in a final concentration of 4.5±0.5 X 104 platelets/jsl (n = 16). A sample ofthese platelet preparations contained 1 white cell for every 300 platelets. The same concentrations of platelets were used in the organ bath experiments as were employed in those experiments in which [3HJnor-epinephrine release was measured.
Determination of 5-hydroxytryptamine. 5-Hydroxytryptamine was quantitated in aliquots ofthe organ chamber contents removed after the second response to electrical stimulation. Samples were frozen at -20°C before assay; no significant decomposition of frozen standards occurred. Measurement was by way of reverse-phase microbore high pressure liquid chromatography and electrochemical detection (14) . Chromatographic separation of 5-id injections was accomplished on a 10 cm X 1.2 mm i.d. column slurry packed with Hypersphere 3-Mm octadecylsilane (C18) (Shandon Southern Instruments Inc., Sewickley, PA). The solvent consisted of 0.1 M sodium acetate, 0.1 M acetic acid, and 3% (vol/vol) acetone, pH 4.5; a flow rate of 100-125 ,ul/min was maintained by way ofa pulseless, fast reciprocating pump (Applied Chromatography Systems, Inc., State College, PA). Amperometric detection was accomplished with a glassy carbon electrode (+0.6 V) and an LC-4B detector (Bioanalytical Systems Inc., W. Lafayette, IN). Quantitation and retention times were compared with authentic standard. With this system, chromatograms of samples ofplatelet-released products contained only one peak which had a retention time identical to that of 5-hydroxytryptamine.
Determination ofadenine nucleotides. Adenine nucleotides were assayed in the same aliquots of the organ chamber contents as was 5-hydroxytryptamine by modification of the luciferase bioluminescent technique (15) . Adenosine diphosphate was converted to adenosine triphosphate with pyruvate kinase and phosphoenolpyruvate and total adenine nucleotides quantitated. The reported value for adenosine diphosphate was the difference between the total and adenosine triphosphate measured.
Drugs. The following pharmacological agents were used: cocaine hydrochloride (generic); acetylcholine chloride, adenosine diphosphate, Statistical analysis. The data were expressed as means±SEM. Statistical evaluation of the data was by Student's t test for unpaired or paired comparisons. n refers to the number of animals fiom which tissues were used. P values < 0.05 were regarded significant.
Results
Effect of aggregating platelets, adenosine diphosphate, and 5-hydroxytryptamine on response ofcoronary artery to electrical stimulation and norepinephrine. In the presence of cocaine Fig. 1 ). When prostaglandin F2,4. was added to coronary rings contracted by aggregating platelets before S2, the resulting tension was significantly greater than that resulting from the prostaglandin alone (Table I) . Compared with rings contracted by prostaglandin F2,.
alone, the relaxations caused by electrical stimulation from 0.5 to 16 Hz were significantly attenuated in the rings contracted in addition by aggregating platelets (Fig. 1 , Table I ). The relaxation in response to 2-Hz stimulation was reduced from 64±14% of tension induced by prostaglandin F2,. to 6.7±1.3% in rings contracted by platelets in addition to prostaglandin F2,4. (P < 0.001). The sensitivity to exogenously added norepinephrine was also significantly reduced by the addition of platelets (Table   I ). The relaxation in response to 3 X 10-8 M norepinephrine was reduced from 69±13% in rings contracted by prostaglandin F2, alone, to 10±1.1% in rings exposed to platelets (P < 0.00 1).
A similar decrease in sensitivity to sodium nitroprusside occurred (PGF,,, 2 X 10-6 M), a response to transmural electrical stimulation (0.5-16 Hz, S) was obtained. After washing the preparation for 1 h, platelets were added to the organ chamber and the resulting contraction allowed to stabilize, before adding prostaglandin F,,, and obtaining a second response to electrical stimulation (S2). Following the second response to electrical stimulation, the concentration of norepinephrine in the organ chamber was increased in half-log unit increments (10-9-10-6 M). Control rings which were not exposed to platelets and rings which were treated with antagonists throughout were run simultaneously in adjacent organ chambers. in rings contracted by platelets compared with rings contracted by prostaglandin F2a alone (log IC50: control solution, -7.78±0.12; platelets -7.25±0.1 1; n = 6, P < 0.05). Adenosine diphosphate (3 X 10-6 M) and 5-hydroxytryptamine (3 X 10-6 M) also significantly attenuated the relaxation in response to electrical stimulation and the sensitivity to norepinephrine of coronary artery rings (Table II) . (Fig. 2) . Adenosine diphosphate (3 X 10-6 M) also significantly reduced the overflow of
[3H]norepinephrine caused by 2 Hz by 28±5% (n = 3). Effects ofantagonists on the inhibitory actions ofaggregating platelets, adenosine diphosphate, and 5-hydroxytryptamine in coronary artery. The combination of methiothepin (10-6 M) and theophylline (l0-4 M) significantly reduced the inhibition caused by platelets of the relaxation of coronary artery rings from 1 to 8 Hz (Table I) . Neither antagonist alone prevented the inhibitory action of platelets on the response of coronary artery rings to electrical stimulation. Methiothepin or theophylline each partially blocked the platelet-induced reduction in sensitivity of coronary rings to exogenous norepinephrine, whereas the combination restored the sensitivity to the control value. The combination of the two antagonists in the absence of platelets did not significantly affect the ratio of the responses to electrical stimulation (S2/S0) or the sensitivity to norepinephrine (Table I) . Methiothepin, alone or in combination with theophylline, blocked the contractile response to platelets (Table I) .
Theophylline (l0-4 M) significantly blocked the reduction in the response of coronary rings to 2-Hz electrical stimulation caused by adenosine diphosphate (3 X 10-6 M, Table II ). Methiothepin significantly reduced the inhibition of the response to electrical stimulation caused by 5-hydroxytryptamine (3 X 10-6 M). The antagonists also blocked the reduction in sensitivity to exogenous norepinephrine caused by each agonist. Methiothepin blocked the contractile response to 5-hydroxytryptamine (3 X 10-6 M) which resulted in significantly greater tension before S2 in the absence of the antagonist (Table II) .
The stimulated overflow of [3H]norepinephrine from strips ofcoronary artery was significantly augmented by methiothepin (10-6 M) but not by theophylline (l0-4 M); the combination of methiothepin and theophylline resulted in a stimulated overflow which was not significantly different from that caused by methiothepin alone (Table III) . Only the combination ofmethiothepin (10-6 M) and theophylline (l0-4 M) significantly reduced the inhibitory effect of platelets on the stimulated overflow of [3H]norepinephrine (Fig. 3) . Neither of these antagonists alone blocked the prejunctional inhibition caused by aggregating platelets.
Theophylline (l0-4 M) significantly attenuated the inhibitory action of adenosine diphosphate (3 X 10-6 M) on the overflow of the adrenergic transmitter caused by 2 Hz from coronary artery to 20±6% (n = 3, P < 0.01).
Concentrations of adenine nucleotides and 5-hydroxytryptamine released by aggregating canine platelets. Under these experimental conditions, platelets released adenosine diphosphate (3.6±1.1 X 10-6 M, n = 7), adenosine triphosphate (2.0±0.7 X 10-6 M), and 5-hydroxytryptamine (6.1±1.2 X l0-7 M) into the control physiological salt solution. These values were not significantly different from those obtained in the presence of methiothepin (10-6 M) and theophylline (l0-4 M).
Discussion
The action of aggregating platelets on adrenergic neurotransmission in canine coronary artery. Since endothelial cells can cause relaxation of the smooth muscle when exposed to the vasoactive substances released from platelets (2-5), the endothelium was removed from the coronary artery rings in this study so that responses to stimulation of adrenergic nerves could be measured during contractions due to prostaglandin F2,. Since accumulation of 5-hydroxytryptamine in coronary adrenergic nerves changes the action of the nerves from beta adrenergic relaxation (8) to serotonergic contraction (9), neuronal uptake of 5-hydroxytryptamine was blocked in the present study with cocaine (9) in order to further study the direct effects of substances released from platelets on the nerves.
It is likely that inhibition of beta adrenergic neurotransmission in the coronary artery by aggregating platelets is due in part to limitation of the postjunctional action of neuronally released norepinephrine, since the sensitivity to the exogenously added neurotransmitter was decreased. The greater contractions caused by the addition of platelets may be partly responsible for the attenuated relaxation responses observed. This is suggested by the similar inhibition in the response to exogenously added norepinephrine as was observed in that to the direct smooth muscle relaxant, sodium nitroprusside. That the greater contractions are the sole reason for the limited relaxations to norepinephrine and electrical stimulation is unlikely, since although methiothepin blocked the contractions, the antagonist, when used alone, did not prevent the inhibition caused by platelets.
Although relaxations in response to both norepinephrine and electrical stimulation were attenuated in the presence ofplatelets, it is also likely that inhibition ofnorepinephrine release by platelets contributes to the reduction in the response to electrical stimulation. This is suggested by the demonstrated reduction in the overflow of tritiated transmitter from strips of coronary artery stimulated electrically in the presence of platelets.
Role ofadenine nucleotides and 5-hydroxytryptamine in inhibiting coronary adrenergic neurotransmission. Adenine nucleotides released from platelets are in part responsible for the inhibition of neurotransmission in the coronary artery. This is suggested by: (a) the inhibition of the response of coronary artery rings to exogenous norepinephrine and electrical stimulation by adenosine diphosphate; (b) the demonstrated inhibition by the nucleotide of the overflow of norepinephrine (16) ; and (c) the release by platelets of vasoactive concentrations of the nucleotides. The rightward shift in the response to norepinephrine caused by adenosine diphosphate cannot be ascribed to contractions, as is the case with platelets; the lower sensitivity may have been mediated by purinergic receptors since theophylline prevented the shift (17) . Antagonism by purine compounds of the beta adrenergic chronotropic action of norepinephrine on the heart has been described (18) .
Though lower concentrations of 5-hydroxytryptamine than adenosine diphosphate are released by canine platelets, an equimolar amount of the amine was a more potent inhibitor of the relaxation responses to electrical stimulation than was the nucleotide. That 5-hydroxytryptamine is the more potent inhibitor is supported by the finding that the reduction in the release of radiolabeled norepinephrine caused by adenosine diphosphate in the present study was similar to that caused by a 30-fold lower concentration of 5-hydroxytryptamine previously determined under identical conditions (1 1).
The serotonergic antagonist, methiothepin, blocked the reduction caused by 5-hydroxytryptamine of the relaxations of coronary rings in response to electrical stimulation and exogenous norepinephrine. Methiothepin is a relatively non selective serotonergic antagonist (19, 20) which may be acting at quite different serotonergic receptors which are located pre-and postjunctionally (21, 22) on coronary adrenergic nerves (11) and arterial smooth muscle (6) . The antagonism by methiothepin in this study may be ascribed to its ability to: (a) block serotonergic receptors on coronary adrenergic nerves which mediate inhibition of norepinephrine release (1 1); (b) block the contraction caused by 5-hydroxytryptamine which, like that due to platelets, may have antagonized the relaxation (6); and (c) block alphaadrenoceptors which partially limit beta adrenergic neurotransmission of coronary arteries (8, 11, 23) .
The combination of theophylline and methiothepin served better to antagonize the inhibitory actions ofaggregating platelets than either of the two agents alone; this was not as a result of altering the amount of 5-hydroxytryptamine or adenine nucleotides released. It is unlikely that the antagonism of the reduced relaxation response of coronary rings to electrical stimulation and exogenous norepinephrine is nonspecific, since values cited in Table I in the presence of the two antagonists, but in the absence of platelets, were not different from control. Furthermore, only the combination ofthe two drugs significantly limited the inhibition of norepinephrine release caused by platelets. The latter effect of the combination is unlikely because of an altered release of norepinephrine caused by the antagonists, since methiothepin alone augmented norepinephrine release, but did not decrease the inhibition by platelets. It is possible that adenine nucleotides mediate the prejunctional inhibitory effects ofplatelets in the presence of methiothepin alone, and conversely, that 5-hydroxytryptamine mediates those in the presence of theophylline alone. This would suggest that in the concentrations released by platelets, adenine nucleotides and 5-hydroxytryptamine are of similar potency. That another vasoactive agent released by platelets is responsible for the residual inhibition in the presence of the combination of the two antagonists cannot be excluded, but this residual inhibition was similar to that observed in the presence oftheophylline for a concentration of adenosine diphosphate comparable with that released by platelets. The evidence that both adenine nucleotides and 5-hydroxytryptamine released from platelets are important mediators ofthe inhibition ofcoronary adrenergic neurotransmission rests on: (a) the similar inhibitory effects determined for either agent individually; (b) the measured release by platelets ofboth agents in concentrations which are vasoactive; and (c) the reduction in the inhibitory effects ofplatelets by antagonists which significantly prevent the and stimulated three times at 2 Hz in the presence and absence of antagonists; before and during the second stimulation platelets were added to the superfusate. The superfusate collected before and during each stimulation was subjected to ion exchange chromatography to determine the amount of intact [3Hlnorepinephrine overflowing the tissue. Data represent the means±SEM of the reduction in norepinephrine overflow which occurred during the second stimulation, expressed as a percentage of the overflow expected from an average of that which occurred during the first and third stimulations. The asterisks denote the significant reduction in stimulated overflow of [3HJnorepinephrine caused by platelets alone, or when theophylline or methiothepin were present throughout the superfusion. The cross denotes the significant attenuation by a combination of both theophylline and methiothepin of the reduction in [3H]norepinephrine release due to platelets. Three preparations were exposed to platelets alone, and five each were treated with each antagonist or the combination of the two.
actions of the two agents. A similar conclusion may be made concerning the endothelium-dependent relaxant action exerted by platelets on coronary arteries; that is that both adenine nucleotides and 5-hydroxytryptamine can participate (2) (3) (4) (5) . In addition to the direct contractile effect ofplatelet-released 5-hydroxytryptamine (2, 6) , and thromboxane A2 (7), inhibition of beta adrenergic neurotransmission by 5-hydroxytryptamine and adenine nucleotides could contribute to coronary vasoconstriction at blood vessel sites where platelets aggregate and release these vasoactive substances.
